Caption Management, LLC Aclaris Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$6.56 - $10.95 $2.91 Million - $4.85 Million
442,900 Added 4385.15%
453,000 $3.1 Million
Q2 2023

Aug 14, 2023
SELL
$7.89 - $10.64 $182,259 - $245,784
-23,100 Reduced 69.58%
10,100 $104,000
Q1 2023

May 15, 2023
BUY
$7.07 - $17.95 $234,724 - $595,940
33,200 New
33,200 $268,000
Q3 2021

Nov 12, 2021
SELL
$13.38 - $18.8 $445,554 - $626,040
-33,300 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$17.08 - $29.6 $568,764 - $985,680
33,300 New
33,300 $585,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email